Tech Company Financing Transactions
Nula Therapeutics Funding Round
Advanced Research Projects Agency for Health (ARPA-H) participated in a $20 million funding round for Nula Therapeutics. The round was announced on 4/16/2026.
Transaction Overview
Company Name
Announced On
4/16/2026
Transaction Type
Debt
Amount
$20,000,000
Round
Undisclosed
Proceeds Purpose
The ARPA-H award will allow us to rigorously explore NLT-101's potential to preserve functional health across multiple organ systems, while our core clinical program in metabolic dysfunction moves forward in parallel.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
961 Arlington Ave N
Saint Petersburg, FL 33705
USA
Saint Petersburg, FL 33705
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
At Nula Therapeutics, we are pioneering a new class of medicines to treat metabolic dysfunction, neurodegeneration, and cancer. At Nula Therapeutics, we are pioneering a new class of medicines to treat chronic disease and extend healthspan by correcting how the nuclear envelope orchestrates gene expression.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Christopher Shepard
Browse more venture capital transactions:
Prev: 4/16/2026: Alloy Therapeutics venture capital transaction
Next: 4/16/2026: Signet Jewelers venture capital transaction
Share this article
News on VC Transactions
We document tech company VC transactions. VC investment data records reported here are sourced from company press releases and news coverage. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs